retatrutide peptide vs tirzepatide Tirzepatide: Key Differences Explained (2026) Retatrutide vs Tirzepatide: Triple Agonist

It is also possible that GLP-1RAs may have a therapeutic effect across traditional diagnostic categories

To view a copy of this licence, visit About this article Cite this article Bonfioli, G.B., Rodella, L., Metra, M

Specifically, the 12 mg arm of retatrutide has shown the highest discontinuation figures of the three compounds at their respective top doses, though investigators have suggested that part of the rate reflects participants who reached weight loss thresholds and chose to discontinue

For patients with type 2 diabetes or obesity who are interested in GLP-1 therapies, discuss the currently licensed options with your GP, practice nurse, or diabetes specialist nurse

10.1002/(sici)1096-9861(19990111)403:2 3.0.co;2-5 43 Mietlicki-BaaseE

2021, p